26 results
8-K
EX-99.5
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
, reputational harm, diminished profits and future earnings, additional reporting obligations and oversight if subject to a corporate integrity agreement … in other countries or jurisdictions, disgorgement, imprisonment, contractual damages,
reputational harm, diminished profits, additional reporting
8-K
EX-99.6
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
, reputational harm, diminished profits and future earnings, and curtailment or restructuring of operations.
Foreign Regulation
In order to market any
424B3
tkz 19sg7gni0n8
10 Nov 22
Prospectus supplement
4:21pm
8-K/A
EX-99.1
wx9rcf kh7oh
3 Feb 21
Other Events
4:59pm
8-K/A
EX-99.3
kn3 onb2n3
3 Feb 21
Other Events
4:59pm